Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

Johnson & Johnson misses the mark on Q4 revenue

By Chris Newmarker | January 22, 2020

Johnson & JohnsonJohnson & Johnson (NYSE:JNJ)  today reported fourth-quarter earnings that beat the consensus forecast on Wall Street, but its sales numbers were slightly off amid declining medical device revenue.

The New Brunswick, N.J.–based pharmaceutical, medical device and consumer products giant reported profits of $4.0 billion, or $1.50 per share, on sales of $20.7 billion for the three months ended Dec. 30, 2019, for a bottom-line gain of 31.8% and sales growth of 1.7% compared with Q4 2018.

Adjusted to exclude one-time items, earnings per share were $1.88, a penny ahead of The Street, where analysts were looking EPS of $1.87 on sales of $20.8 billion.

Pharmaceutical sales were up 3.6% to $42.2 billion in 2019.

Get the full story on our sister site MassDevice. 

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moderna
Moderna revenue soars in Q4 thanks to COVID-19 vaccine
SARS-CoV-2 COVID-19
Is COVID-19 herd immunity elusive or within reach?
Catalent
Catalent to acquire Acorda’s manufacturing and packaging operations
COVID-19 therapies vaccines coronavirus
Pfizer and BioNTech to offer COVID-19 vaccine to placebo recipients  

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards